VectorY Therapeutics
在场
高管
查看带有其 11 名主要高管的组织结构图
VectorY Therapeutics 搜索最多的简介
- Sander van Deventer, Co-Founder and Chief Executive Officer
- Arno de Wilde, Director
- Marco Boorsma, Member of the Supervisory Board
高管在VectorY Therapeutics变化
- Adam Rosenberg已作为Chairman of the Board加入公司 (新闻发布的2024七月10号).
创建提醒
跟踪 VectorY Therapeutics 的高管变动
生物技术
VectorY Therapeutics 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Evommune 刚刚宣布为 115 筹款数百万美元。 (公布2024十一月4号).
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
生物技术 行业的其他推荐联系人
消息
VectorY Therapeutics 的最新新闻稿
- Press releases and news — VectoryTx
- VectorY Appoints Seasoned Biotech Leader Adam Rosenberg as Chair of the Board — VectoryTx
- VectorY to participate in key sector events in June 2024 — VectoryTx
- Press releases and news — VectoryTx
- UMC Utrecht and VectorY Therapeutics collaborate in ALS Biomarker Study — VectoryTx
- VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases — VectoryTx
- Press releases and news — VectoryTx
- VectorY to Present at the ASGCT Annual Meeting in May 2023 — VectoryTx
- VectorY to Present at the Bio€quity Europe Conference in May — VectoryTx
- VectorY to Participate in Key Sector Conferences in April 2023 — VectoryTx
- View more press releases Close
通过电子邮件
